Abstract Vaccinia virus (VACV) continues to be used in immunotherapy for prevention of 20 infectious diseases and treatment of cancer since its use for the eradication of smallpox. 21
on July 14, 2017 by guest http://jvi.asm.org/ Downloaded from plaque purification marker ( Figure 2B ). The success rate of A46R gene deletion in RFP-74 positive plaques for gRNA A1, gRNA A2 and gRNA A3 is 80% (12/15), 80% (12/15) and 75 85% (6/7) respectively ( Figure 2C ; Table 1 ) whereas there was no deletion detected in the 76 28 control plaques without prior exposure to CRISPR/Cas9 and the guide RNA (data not 77 shown). 78
In certain cases, there is a need to modify two or more genes in VACV to generate a mutant 79
virus. Using the current method, more than four weeks are required to achieve modification 80 of two genes in the virus. To test whether multiple genes of VACV can be edited 81 simultaneously by gRNA-guided Cas9, the N1L region and the A46R region were targeted. 82 N1L gRNA N2 and A46R gRNA A2 were used to guide Cas9 editing of the VACV genomes 83 (Table 1 ). The shuttle vector carrying GFP for the N1L region ( Figure 3A ) and donor vector 84 carrying RFP for the A46R region were used for homologous recombination ( Figure 3A) . 85
Plaques double-positive for both GFP and RFP were purified over 3-5 rounds ( Figure 3B) . 86 N1L and A46R dual deletions were found in nine of 15 double-positive plaques (60%) 87 ( Figure 3C ). This result demonstrates that gRNA-guided Cas9 can simultaneously and 88 rapidly induce homologous recombination across multiple target sites on VACV genome. 89
Finally, using a bioinformatics approach for computing all VACV genome targets, we 90 generated a set of 8,964 unique gRNA gene sequences that maximally target specific genes 91 in VACV but minimally target other locations in the genome (data not shown but available 92 upon request). Maximally efficient targeting of Lister clone VACV107 by a gRNA was 93 achieved by identifying 19nt sequences followed by the nucleotides "NGG" (PAM motif) 94 where N can be either A, G, C or T. Identical motif sequences present in multiple 95 genes/locations (usually at either end of the genome) were further excluded, and thus only 96 unique motif sequences were retained in our final dataset (data not shown but available 97 upon request). The same search and exclusion criteria were also applied to find gRNA 98 sequences in the reverse complementary strand of coding regions of VACV107. Unique 99 motif sequences are shown in our final dataset (data not shown but available upon request). 100 on July 14, 2017 by guest http://jvi.asm.org/
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Of note, the two N1L gRNAs and all three A46R gRNAs that were functionally validated in 101 this study are covered by the dataset (data not shown but available upon request). 102
103
To generate a new mutant of VACV, the current approach can take up to 10 rounds of 104 plaque purification (lasting 4-6 weeks), and often results in an unsuccessful outcome in 105 obtaining the desired virus with a purification marker in the target region. In this study, we 106 demonstrate that the gRNA-guided Cas9 system greatly increases the efficiency of 107 The bold and underlined is the Protospacer Adjacent Motif (PAM) sequence located on the immediate 3' end of the gRNA recognition sequence. 
